Biology of the TAM Receptors
Open accessThe DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Abstract
The TAM receptors--Tyro3, Axl, and Mer--comprise a unique family of receptor tyrosine kinases, in that as a group they play no essential role in embryonic development. Instead, they function as homeostatic regulators in adult tissues and organ systems that are subject to continuous challenge and renewal throughout life. Their regulatory roles are prominent in the mature immune, reproductive, hematopoietic, vascular, and nervous systems. The TAMs and their ligands--Gas6 and Protein S--are essential for the efficient phagocytosis of apoptotic cells and membranes in these tissues; and in the immune system, they act as pleiotropic inhibitors of the innate inflammatory response to pathogens. Deficiencies in TAM signaling are thought to contribute to chronic inflammatory and autoimmune disease in humans, and aberrantly elevated TAM signaling is strongly associated with cancer progression, metastasis, and resistance to targeted therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myelin debris clearance during cuprizone consumption is regulated by receptor tyrosine kinases, such as MER proto-oncogene, tyrosine kinase (MERTK) that recognize phosphatidylserine on apoptotic cells [198, 199].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [199]
In the citing paper
“Activation of the tyrosine kinase of TAM receptors upon ligand binding recruits the p85 subunit of PI3K and activates PI3K/Akt signaling [147–150].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [148]
In the citing paper
“Microglia also express several families of receptors that enable phagocytosis or endocytosis of apoptotic cells, protein aggregates, and lipoprotein particles. These receptors include scavenger receptors, such as CD36, SR1, and MARCO (20); LDL receptor family members, such as LDLR, ApoER2, and VLDL (21); and three receptor tyrosine kinases, Tyro3, Axl, and Mertk (TAM) (22).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [22]
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · cited 1×
“1994) confirmed their segregation into a structurally distinctive family of orphan RTKs (Manning et al. 2002b).”
BackgroundMembrane lipids: where they are and how they behave
van Meer, G., Voelker, D. R., & Feigenson, G. W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2330 · Cited by 7,157
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193 · cited 1×
“3) (Iwasaki and Medzhitov 2004).”
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · cited 1×
“Here, a large genome-wide association study identified polymorphisms in the Mertk gene as risk factors for the development of MS (Ma et al. 2011; Sawcer et al. 2011).”
Backgroundthe Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 1×
“Microglia, the tissue macrophages of the brain, also express Axl and Mer (Gautier et al. 2012), and there is evidence that TAM signaling through these receptors controls the phagocytosis of ACs and the inhibition of inflammation in the CNS just as it does in macrophages and DCs in the periphery (Grommes et al.”
BackgroundSOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 2×
“In so doing, Axl switches the IFNAR signaling modality from proinflammatory to immunosuppressive, by driving the activation of the genes encoding the suppressor of cytokine signaling (SOCS) 1 and 3 (Rothlin et al. 2007; Yoshimura et al. 2007).”
BackgroundRequirement for neuregulin receptor erbB2 in neural and cardiac development
Lee, K.-F., Simon, H., Chen, H., Bates, B., Hung, M.-C., & Hauser, C. (1995) · Nature · doi:10.1038/378394a0 · Cited by 1,290 · cited 1×
“RTKs play essential roles in embryonic development, even single loss-of-function mutations in RTK genes often result in an embryonic-lethal phenotype (Gassmann et al. 1995; Lee et al. 1995; Soriano 1997; Arman et al. 1998).”
BackgroundActivation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhang, Z., Lee, J. C., Lin, L., Olivas, V., Au, V., LaFramboise, T., Abdel-Rahman, M., Wang, X., Levine, A. D., Rho, J. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2330 · Cited by 1,224 · cited 1×
“Axl up-regulation and activation have also been found to be a clinically significant feature of resistance to EGF receptor inhibitor and PI3K inhibitor therapies for nonsmall-cell lung cancer (Zhang et al. 2012; Byers et al. 2013).”
BackgroundPhagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 6×
“The TAMs play similarly critical roles in AC clearance by phagocytes of the immune system—most prominently macrophages (Scott et al. 2001).”
BackgroundInfluentialAberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,148 · cited 1×
“RTKs play essential roles in embryonic development, even single loss-of-function mutations in RTK genes often result in an embryonic-lethal phenotype (Gassmann et al. 1995; Lee et al. 1995; Soriano 1997; Arman et al. 1998).”
BackgroundSelf-citation
Cited by
Items 501–600 of 600
Differential TAM receptor regulation of hepatic physiology and injuryPreprint
Zagórska, A., Través, P. G., Jiménez-García, L., Strickland, J. D., Tapia, F. J., Mayoral, R., Burrola, P., Copple, B. L., & Lemke, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.990143 · Cited by 1
Self-citationGAS6-AXL signaling triggers actin remodeling and macropinocytosis that drive cancer cell invasionPreprint
Zdżalik-Bielecka, D., Poświata, A., Kozik, K., Jastrzębski, K., Schink, K. O., Brewińska‐Olchowik, M., Piwocka, K., Stenmark, H., & Miączyńska, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.15.993147 · Cited by 1
“TAM receptors are dispensable for embryonic development but participate in phagocytic clearance of apoptotic cells (efferocytosis) in adult organisms (Lemke, 2013; Lemke & Burstyn-Cohen, 2010; Nguyen et al, 2013).”
BackgroundCOVID-19 and Rheumatoid Arthritis share myeloid pathogenic and resolving pathwaysPreprint
MacDonald, L., Otto, T. D., Elmesmari, A., Tolusso, B., Somma, D., McSharry, C. P., Gremese, E., McInnes, I. B., Alivernini, S., & Kurowska‐Stolarska, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.26.221572 · Cited by 2
MerTK mediates the immunologically silent uptake of alpha-synuclein fibrils by human microgliaPreprint
Dorion, M.-F., Senkevich, K., Yaqubi, M., Kieran, N. W., Chen, C. X., MacDonald, A., Luo, W., Wallis, A., Shlaifer, I., Hall, J. A., et al. (2023) · bioRxiv · doi:10.1101/2023.03.04.531108 · Cited by 1
Limber, C., Wagner, G. P., & Prum, R. O. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.21.624532 · Cited by 1
Paisley, C. E., Sakers, K., Nagendren, L., Chen, X., Mazzoni, F., Finnemann, S. C., Eroğlu, Ç., & Kay, J. N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.20.700660 · Cited by 1
Monogenic predisposition to systemic lupus erythematosus and efferocytosis
Guillet, S. (2019) · theses.fr (ABES) · doi:10.70675/f38861b1z1aa3z4ae5zaf45ze9aefb5c6af3 · Cited by 1
Ching, Y. M., Narayanan, S., Klomp, J. A., Isermann, T., Loewe, S., Chang, W.-H., Waters, A. M., Peña, S. R. N., Baldelli, E., Martin, C. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743026 · Cited by 2
A Particularly Discriminating Receptor
Whitty, A. (2015) · Cell Systems · doi:10.1016/j.cels.2015.07.004
Axl RTK and microRNAs in urogenital cancers
Fritz, H. (2015) · Lund University Publications (Lund University)
Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_176-1
The Role of MERTK in Central Inflammatory Demyelination
Dwyer, C. (2020) · Minerva Access (University of Melbourne)
Retinal Degeneration Secondary to MERTK Mutations: Potential Candidate for Gene Therapy
Shen-Sampas, J. H., Duret, S., & Duncan, J. L. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000374
Owlett, L. D., Karaahmet, B., Le, L., Belcher, E. K., Dionisio-Santos, D. A., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2021) · Research Square · doi:10.21203/rs.3.rs-991983/v1
ADAM17 inhibition effects on Mer shedding
Salmi, L., Patrucco, F., Molinari, L., Bellan, M., Sainaghi, P. P., & Castello, L. M. (2022) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.20.02734-2
Menshawy, N. E., El‐Said, G., Abouzeid, T., & Farag, N. A. (2022) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2022.103018
Wachtel, C. (2021) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.61402
Brown, M., & Pinato, D. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101916
Basu, A., & Ghosh, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736212208.793562895
Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_176
Halmos, B., & Liu, X. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_114-1
Brown, M., & Pinato, D. J. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101916-1
Reddy, S. P. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735287583.793583616
Halmos, B., & Liu, X. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_114
Receptor Tyrosine Kinases and Their Ligands
Ferguson, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00226-1
Cucunawangsih, C., Wijaya, R. S., Lugito, N. P. H., & Suriapranata, I. M. (2022) · Hematology Reports · doi:10.3390/hematolrep14040051
“Moreover, LG domains are required for PS binding to TAM receptors, and thus cleavage of this PS site may reduce TAM receptor signaling that plays an essential role in limiting excessive immune response [11].”
BackgroundPrognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas
Öz, Ö., Argon, A., Kebat, T. A., Özdemir, Ö., & Yakan, S. (2023) · Indian Journal of Pathology and Microbiology · doi:10.4103/ijpm.ijpm_1002_21
Correa, A. A. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-10042023-162038
Divoux, J., Rolland, S., Delille, R., Levin, C., Martin, V., Young, P. A., Meyer-Losic, F., & Klinz, S. G. (2023) · European Journal of Immunology · doi:10.1002/eji.202250186
Virtual screening of natural product as TAM family of RTK inhibitor
Dholakia, S. P., Kher, M. N., Sharma, A., Sangani, R. S., & Sureja, D. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15457-7.00010-1 · Cited by 1
Belastung, Muskelreparatur, Muskelremodulation, Immunsystem
Laube, W. (2023) · Springer eBooks · doi:10.1007/978-3-662-67753-7_11
Plasma proteomic associates of infection mortality in UK BiobankPreprint
Drozd, M., Hamilton, F., Cheng, C. W., Lillie, P. J., Brown, O. I., Chaddock, N., Savic, S., Naseem, K. M., Iles, M. M., Morgan, A. W., et al. (2024) · medRxiv · doi:10.1101/2024.01.21.24301569
“(25,26) This interaction of activated TAM receptors with type I interferon receptors is thought to allow a transition from pro-inflammatory to anti-inflammatory interferon signalling required during resolution of the innate immune response.”
BackgroundLeite, N. P. D. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2023.tde-08022024-154139
Role of TAM Receptors in Antimalarial Humoral Immune Response
John, L., & Vijay, R. (2024) · Pathogens · doi:10.3390/pathogens13040298 · Cited by 1
Engelmann, J., Waizenegger, J. S., Riecken, K., Fehse, B., Weinhold, N., Raab, M. S., Hesse, E., Taipaleenmäki, H., Pantel, K., Bokemeyer, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4256896/v1
Yu, Z., Gutu, A., Kim, N., & O’Shea, E. K. (2024) · Qeios · doi:10.32388/td1oxf
Yu, Z., Gutu, A., Kim, N., & O’Shea, E. K. (2024) · eLife · doi:10.7554/elife.101779.1
Ovarian expression of MerTK and its ligand Pros1 in non-pregnant estrus and pregnant mice
Konuk, E., Cernomorcenco, A., & Katırcı, E. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10292-4
“TAM RTKs was first cloned in 1991 and remained as orphan receptors until 1995 when Pros1 and Gas6 were identified as their ligands (Lemke 2013; Zagórska et al. 2014; Tutusaus et al. 2020).”
InfluentialApostolo, D., Ferreira, L. L., D’Onghia, D., Vincenzi, F., Vercellino, N., Perazzi, M., Pirisi, M., Cantello, R. M., Minisini, R., Mazzini, L., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04671-x
“In fact, these receptors are involved in regulating several processes including cell growth, differentiation, proliferation, apoptosis, and modulation of immune response [12–15].”
Host responses to S. pneumoniae in wild type and Mertk mutant mice
McPeek, M., Martin, J. R., Gomez, J. C., Li, Y., Dang, H., Earp, H. S., & Doerschuk, C. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0320660
“Mertk (myeloid-epithelial-reproductive proto-oncogene tyrosine kinase) is a receptor tyrosine kinase and a member of the TAM family, which also includes Tyro3 and Axl [13,14].”
Arterial Drug Delivery in the Future: Addressing Complex Problems as Acute Ischemic Stroke
Joshi, S., & Ramos, A. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-80173-0_23
Jin, J., Ma, L., Li, L., Zhou, X., Zhu, S., Shen, K., Xu, Q., Jiang, B., Gu, Y., Ding, Q., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03241-6
“The unique programming of resident and recruited alveolar macrophages during acute lung injury has been thoroughly examined [19, 32, 34, 35].”
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism
Clark, J. R., Panagopoulos, V., Noll, J. E., Mrozik, K. M., Bradey, A. L., Croucher, P. I., Zannettino, A. C. W., Vandyke, K., & Hewett, D. R. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104842
Bourebaba, N., Domagała, J., Pander, M., & Bourebaba, L. (2025) · Research Square · doi:10.21203/rs.3.rs-7698110/v1
Tim-4 internalizes apoptotic cells through Axl-mediated signal transductionPreprint
Park, D., Moon, B., Jeon, J., Oh, E., Han, J., Lee, J., Hwang, E., Lee, C. S., & Jeong, D. (2025) · Research Square · doi:10.21203/rs.3.rs-7580891/v1
AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosisPreprint
Kangboonruang, K., Drabent, P., Maksut, F., Heintzé, M., Lepelletier, Y., Lhermitte, L., Féroul, M., Letard, S., Kabore, C., Brenet, F. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.03.686205
Ruicci, K. M., Meens, J., Plantinga, P., Stecho, W., Pinto, N. C., Yoo, J., Fung, K., MacNeil, D., Mymryk, J. S., Barrett, J. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13100910
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525169
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14927005
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14927002
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525178
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14926993
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14926990
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525181
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525175
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525163
Wu, H., Zheng, J., Xu, S., Fang, Y., Wu, Y., Zeng, J., Shao, A., Shi, L., Lü, J., Mei, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13525172
Ruicci, K. M., Meens, J., Plantinga, P., Stecho, W., Pinto, N. C., Yoo, J., Fung, K., MacNeil, D., Mymryk, J. S., Barrett, J. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13100907
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14926999
Zhou, H., Hu, L., Li, J., Ruan, W., Cao, Y., Zhuang, J., 許, 珩., Peng, Y., Zhang, Z., Xu, C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14926996
Owlett, L. D., Karaahmet, B., Le, L., Belcher, E. K., Dionisio-Santos, D. A., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2022) · Figshare · doi:10.6084/m9.figshare.19136122
Huang, Z., Weng, X., Tan, H., Li, W., Pang, Z., Jiang, M., Cai, S., Zheng, D., Gao, J., Lin, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8532127/v1
Bowden, K. A., Wright, C., Clark, S. J., Correa, T. F., Johnston, S. A., Marriott, H. M., Francis, S., & Prince, L. R. (2026) · Journal of Inflammation · doi:10.1186/s12950-026-00495-9
“Via Gas6, MerTK binds to the cell surface ‘eat-me’ receptor, phosphatidylserine on apoptotic cells, which initiates cytoskeletal rearrangements to allow the formation of a phagocytic cup around the apoptotic cell and efferosome maturation [21].”
Parinot, C. (2015) · theses.fr (ABES) · doi:10.70675/d9dc4ed9zdf25z4c75z9e2ez4776a72bb628
“Les récepteurs TAM sont surexprimés dans une grande variété de cancers humains, associés à des pathologies agressives et une espérance de survie courte, avec la capacité d’activer les voies de signalisation oncogéniques et de survie cellulaire (Lemke, 2013; Linger et al., 2008).”
BackgroundInfluentialBaillet, N. (2018) · theses.fr (ABES) · doi:10.70675/15164ec9z568ez44c3zbde4z9fce05a9b248 · Cited by 2
Molecular and cellular basis of phosphatidylserine receptors mediated flavivirus infection
Dejarnac, O. (2017) · theses.fr (ABES) · doi:10.70675/77142d81ze3a4z497cz85c3zcfd1edd1ce35
Bescont, J. L. (2020) · theses.fr (ABES) · doi:10.70675/35725804z8259z40f1z80a2z2ef677891579
Le mimétique de SMAC GDC-0152 : un nouvel immunomodulateur dans les glioblastomes
Snacel-Fazy, E. (2023) · theses.fr (ABES) · doi:10.70675/7e5e377fzaaa9z4f1dzbde6z9586007f6c3d
Microparticle uptake reduces efferocytic capacity of macrophages
Mishra, S., Aggarwal, B., Anant, P. S., Bajaj, A., & Jhunjhunwala, S. (2026) · Biomaterials Science · doi:10.1039/d5bm01447f
Hassen, H., Tarko, T., & Franczyk‐Żarów, M. (2026) · Applied Sciences · doi:10.3390/app16115254
Sha, L., & Jha, S. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.04.008
Doğan, S. C., Zontul, C., Atas, M., Özmen, E., Kaya, G. C., Taş, A., & Karadağ, A. (2026) · Life · doi:10.3390/life16071066
“The TAM receptor tyrosine kinase family, consisting of TYRO3, AXL , and MERTK , represents a crucial signaling axis involved in the regulation of immune responses and control of inflammation [6].”
Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer’s disease therapy
Ding, X., Hu, X., Xue, W., An, Y., Cheng, W., Zhang, S., Lei, A., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1820099
“The TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases has been identi fi ed as a central regulator of efferocytosis and immune homeostasis (16 – 18).”
Li, R. K., Wei, B., Sun, B., Li, M. C., Wang, Y., Zhao, X., Yao, Y., Zou, D. W., & He, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1887429
“…ligand, the growth arrest-speci fi c protein 6 (GAS6), AXL participates in various signal transduction cascades and plays a critical role in various biological processes including cell proliferation, survival, migration, efferocytosis, angiogenesis, platelet aggregation and fi brosis (69, 70).”
Gustina, S., Hasbi, H., Azis, I. U., Maulana, T., & Hamsir, S. N. (2026) · Veterinary Medicine International · doi:10.1155/vmi/5512313
Bao, Y., Ma, F., Qi, X., Gu, M., Zhu, L., Shi, C., Na, R., & Zhang, W. (2026) · Biology · doi:10.3390/biology15151327 · Cited by 1
“MAC-associated interactions involving GAS6-TAM and CX3CL1-CX3CR1 were enriched in both inactive and cystic states, consistent with immune-mediated modulation of ovarian function [56].”
Zhang, H., Miao, Y., Ma, T., Zhang, X., Wang, Y., Zhang, Y. W., Wang, M., Pang, K., Zhou, Z., Zhao, P., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324955
Huang, Y., Mavinkurve, A., Sabikunnahar, B., Stevens, B., & Lemke, G. (2026) · Nature Communications · doi:10.1038/s41467-026-76728-5
“We also examined the expression of Gas6, the ligand that binds and activates all TAM receptors 10,30 .”
Self-citationZhao, J., & Cai, J. (2026) · Critical Public Health · doi:10.1080/09581596.2026.2718558
Kim, T. Y., Bhalla, M., Park, U., Hyeon, S. J., Hwang, I., Seo, Y., Youn, W., Lee, J.-A., Lee, J.-H., Lee, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.23.746508
Expression of TAM receptors and their ligands in unexplained recurrent pregnancy loss
Konuk, E., Simsek, M., Yıldırım, F., & Demır, N. (2026) · Immunologic Research · doi:10.1007/s12026-026-09836-5
“…inhibition of apoptosis, differentiation, proliferation, cell growth, epithelial-mesenchymal transition (EMT), efferocytosis, and hemostasis [ 22 , 28 , 30, 31] When GAS6 activates TAM receptors, it facilitates platelet stabilization and promotes hemostasis whereas PROS1 has an independent…”
Kondo, S., Owaki, K., Hamasaki, G., Inukai, T., Kinoshita, J., Ito, T., Nakamura, S., & Shibata, T. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1939483
“Growth arrest-speci fi c protein 6 (Gas6) is a vitamin K – dependent ligand of the TAM receptor family, including Axl, and functions as a negative regulator of innate immune activation (Lemke, 2013).”
Yan, Z., Beus, M., Han, Z., Pan, L., Wang, Y., Lu, J., Weidenhammer, L. B., Liu, L., Rosario, S. R., Lee, J., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117962
Zhang, P., Su, Z., Chen, L., Chen, Z., Wang, Y., Lu, W., Wang, K., Yu, B., Gong, T., Wang, J., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.78547
Structural basis of phosphatidylserine enhancement of Gas6 ligand-induced Axl activationPreprint
Fournier, N., Arango, M. C., Vasquez, M. L., Singh, P. K., Bingham, J., 甘華臣, Smith, A. W., & Starbird, C. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755801
“24 Graphical depictions of this complex are informed mainly by the dogma that receptor tyrosine kinases are activated by ligand-induced dimerization 25 , rather than direct knowledge of this assembly studied in TAMs.”
Chaudhari, A., & Goyal, S. N. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120231
Yang, S., Li, R., Yu, C., Li, J., & Zhou, X. (2026) · MedComm · doi:10.1002/mco2.71031
Sridhar, S., Mohan, K., Kizhake, S., Natarajan, A., Kelly, D. L., & Mathew, G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.13.758818
Discovery of Small Molecules Targeting Mer-TK as Novel Therapies for Cardiovascular Diseases
Sharma, A. (2026) · European Journal of Biomedical and Life Sciences · doi:10.29013/ejbls-26-2.3-50-65
BindingDB Entry 50048020: Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors.
BindingDB (2018) · UC San Diego · doi:10.7270/q208679k
BindingDB Entry 50020942: Recent discovery and development of AXL inhibitors as antitumor agents.
BindingDB (2025) · UC San Diego · doi:10.7270/q2z89j03
BindingDB Entry 50014524: UNC5293, a potent, orally available and highly MERTK-selective inhibitor.
BindingDB (2022) · UC San Diego · doi:10.7270/q2m90dgj
BindingDB Entry 50003313: Highly Selective MERTK Inhibitors Achieved by a Single Methyl Group.
BindingDB (2020) · UC San Diego · doi:10.7270/q2k076zk
Metadata
- Authors
- Lemke, G.
- Affiliations
- Salk Institute for Biological Studies (US)
- Corresponding author
- Lemke, G.
- ORCID
- Lemke, G.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2013-11-01
- Volume
- 5
- Issue
- 11
- Pages
- a009076-a009076
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3809585
- OpenAlex
- W2153326117
- Cited by
- 598
- References
- 184
- Citations by year
- 2026: 49 · 2025: 43 · 2024: 47 · 2023: 61 · 2022: 57 · 2021: 82 · 2020: 55 · 2019: 48 · 2018: 42 · 2017: 43 · 2016: 33 · 2015: 26 · 2014: 10 · 2013: 2
- Type
- posted content
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- TAM receptors, Tyro3, AXL, Mer, receptor tyrosine kinase, Gas6, protein S, efferocytosis, phagocytosis, innate immunity, inflammation, autoimmune disease, tumor progression, metastasis, drug resistance, tissue homeostasis
- MeSH terms
- c-Mer Tyrosine Kinase, Axl Receptor Tyrosine Kinase, Animals, Autoimmune Diseases, Cell Membrane, Gene Expression Regulation, Humans, Ligands, Neoplasms, Phagocytosis, Proto-Oncogene Proteins, Virus Diseases, Signal Transduction, Apoptosis, Receptor Protein-Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.